{"id":"W2979491005","doi":"10.1182/blood.v120.21.3677.3677","title":"MEDI-551, a Humanized Monoclonal Anti-CD19, in Adults with Relapsed or Refractory Advanced B-Cell Malignancies: Results From a Phase 1/2 Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Neutropenia; Refractory (planetary science); Internal medicine; Toxicity; Adverse effect; Tumor lysis syndrome; Phases of clinical research; Gastroenterology; Oncology; Chemotherapy; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001826712,0.0007915263,0.00112869,0.000231693,0.0002395783,0.000595411,0.0004486392,0.0006458474,0.0009834222],"category_scores_gemma":[0.0006538545,0.0002622803,0.0007234418,0.0002636133,0.0004663359,0.0004862976,0.0002324119,0.001195219,0.0003566295],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005900954,"about_ca_system_score_gemma":0.0006155622,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008850009,"about_ca_topic_score_gemma":0.001597083,"domain_scores_codex":[0.9996419,0.0001777736,0.00002664932,0.00005533555,0.00004516502,0.00005315501],"domain_scores_gemma":[0.9995314,0.00009648933,0.0001091675,0.00003174824,0.00003269512,0.0001986445],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3648247,0.06155557,0.07796222,0.001470059,0.003698654,0.001073815,0.001089314,0.004030213,0.2067692,0.0002872004,0.005283687,0.2719554],"study_design_scores_gemma":[0.1932557,0.6583478,0.1236921,0.00008583705,0.002589363,0.001463821,0.0001833383,0.001994876,0.0118564,0.0001529589,0.006329035,0.00004855065],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951583,0.003134997,0.0002929589,0.0001445393,0.00001705993,0.0003503771,0.0003738893,0.00003262685,0.0004953443],"genre_scores_gemma":[0.9936703,0.002679108,0.0008932815,0.0005351196,0.00006961947,0.000284503,0.001459689,0.0000131828,0.0003950027],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001826712,"threshold_uncertainty_score":0.009660721,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02534597911555026,"score_gpt":0.3122596468222849,"score_spread":0.2869136677067347,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}